JBT Marel financials
$110.32−0.75%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 |
|---|---|---|---|---|---|---|
| Revenue | $981.0M | $936.0M | $1.01B | $1.00B | $935.0M | $854.0M |
| Gross profit | $359.0M | $329.0M | $348.1M | $359.8M | $335.0M | $292.0M |
| Gross margin | 36.6% | 35.1% | 34.5% | 35.9% | 35.8% | 34.2% |
| Operating income | $46.0M | $68.0M | $72.3M | $102.1M | $48.0M | -$33.0M |
| Net income | $28.0M | $45.0M | $53.1M | $66.0M | $3.0M | -$173.0M |
| Net margin | 2.9% | 4.8% | 5.3% | 6.6% | 0.3% | −20.3% |
| Diluted EPS | $0.54 | $0.86 | $1.03 | $1.26 | $0.07 | $-3.35 |
| EBITDA | $112.0M | $136.0M | $147.2M | $164.5M | $130.0M | $28.0M |
| Operating cash flow | $102.0M | $119.0M | $117.4M | $87.7M | $103.0M | $34.0M |
| Free cash flow | $77.0M | $93.0M | $83.5M | $56.5M | $84.0M | $14.0M |
| Diluted shares | 52.2M | 52.4M | 51.8M | 52.3M | 52.2M | 51.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $93.0M | $211.0M | $168.0M | $114.9M | $111.8M | $101.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.68B | $1.84B | $1.88B | $1.91B | $1.92B | $1.99B |
| Total assets | $8.01B | $8.16B | $8.19B | $8.20B | $8.25B | $8.00B |
| Total liabilities | $3.53B | $3.68B | $3.73B | $3.78B | $3.88B | $3.89B |
| Shareholders' equity | $4.47B | $4.48B | $4.46B | $4.42B | $4.37B | $4.11B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology